MYR GAAP EPS of $3.82 beats by $0.88, revenue of $1.25B beats by $100M (MYRG:NASDAQ)

MYR Group Inc. reported Q3 GAAP EPS of $3.82, exceeding estimates by $0.88, with revenue of $1.25B, up 31.5% year-over-year and $100M above expectations. The company cited a change in revenue types as benefiting margins.

Original reporting
Published Oct 28, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MYRG
Bullish
high confidence
Mentioned
$MYRG
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$MYRGBullishMed
01

Why it matters

The earnings beat provides a fresh catalyst for short‑term trading.

02

Market read

Earnings beat could trigger a brief rally in MYRG and influence sector sentiment.

03

What to watch

Guidance for Q4 and cash flow outlook were not disclosed.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

MYR Group released its Q3 2026 earnings via a press release on Seeking Alpha.

Company-level read

Ticker impact

$MYRGBullishHigh confidence
Context

Q3 GAAP EPS of $3.82 beats expectations by $0.88 and revenue of $1.25B beats by $100M.

Expected impact

upward pressure as the market prices in the earnings beat.

Evidence & confidence

Both EPS and revenue exceeded estimates, providing fresh positive catalyst.

Market effects

Strong performance may lift other specialty chemicals peers.

Positive for U.S. industrial sector.

Limited to investors tracking earnings season.

Counterpoint

Some analysts may view the beat as already priced in, limiting upside.

Key entities

  • MYR Group Inc.

    Specialty chemicals manufacturer reporting Q3 earnings.

Related articles

$MYRGMed

KeyBanc upgrades MYR Group stock rating on balanced portfolio

KeyBanc upgraded MYR Group (NASDAQ:MYRG) to Overweight with a $361 price target, citing its balanced portfolio and strong fundamentals. The stock is down 44% in six months but is considered undervalued. MYR Group reported Q3 2026 earnings of $3.82 per share on $1.26B revenue, beating estimates, with a 38% increase in backlog to $3.68B. Revenue grew 32% YoY, driven by strong demand in commercial, industrial, and transmission sectors.

$MYRGMedAI 9/10

MYR Group (MYRG) Q3 2026 Earnings Call Transcript

MYR Group (MYRG) reported Q3 2026 record revenues of $1.26B, up 32% YoY, with T&D and C&I segments growing 10% and 58% respectively. Net income rose 86% to $60M, while backlog reached $3.68B. The company attributed growth to acquisitions and market demand, and announced a $100M share repurchase program.

$MYRGMedAI 8/10

What MYR Group (MYRG) Said on Its Q3 Earnings Call

MYR Group (MYRG) reported Q3 revenue of $555M, up 10%, with gross margin expanding to 13.6%. Operating margins improved in both segments. Backlog reached a record $3.68B. Management expects 18-22% C&I revenue growth and 10-13% T&D growth next year. The company has $650M borrowing availability and a new $100M share buyback program.

$MYRGHighAI 8/10

MYR Group gains on strong earnings and revenue beat

MYR Group Inc (MYRG) reported Q3 earnings of $3.82 per share, beating estimates by $0.83, with revenue of $1.26B, up 32% YoY. Shares rose 10% in after-hours trading. Net income increased to $60M from $32.1M YoY. The company's backlog grew 38.2% to $3.68B. MYR's board approved a $100M share repurchase program.